Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Other financing activities: 2015-2024

Historic Other financing activities for Cartesian Therapeutics (RNAC) over the last 5 years, with Dec 2024 value amounting to $66,000.

  • Cartesian Therapeutics' Other financing activities was N/A to $43,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $588,000, marking a year-over-year change of. This contributed to the annual value of $66,000 for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Cartesian Therapeutics' Other financing activities is $66,000, which was down 40.00% from $110,000 recorded in FY2022.
  • In the past 5 years, Cartesian Therapeutics' Other financing activities registered a high of $4.4 million during FY2020, and its lowest value of $66,000 during FY2024.
  • Over the past 2 years, Cartesian Therapeutics' median Other financing activities value was $88,000 (recorded in 2022), while the average stood at $88,000.